NCT03183505View on ClinicalTrials.gov

Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

October 5, 2018

Study Completion Date

November 29, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Anyu Peibo

Anyu Peibo Capsule, 0.8g twice per day, oral after breakfast and supper

DRUG

Placebo

Placebo Capsule, twice per day, oral after breakfast and supper

Trial Locations (8)

100088

Beijing Anding Hospital，Capital Medical University, Beijing

100096

Beijing HuiLongGuan Hospital, Beijing

136000

Brain Hospital of Jilin Province, Siping

200030

Shanghai Mental Health Center, Shanghai

330029

Jiangxi Mental Hospital, Nanchang

430022

Wuhan Mental Health Center, Wuhan

610041

West China Hospital, Sichuan University, Chengdu

710061

XI'AN Mental Health Center, Xi’an

All Listed Sponsors
collaborator

Su Zhou YiHua Biotechnology Co. LTD

UNKNOWN

lead

Shanghai Mental Health Center

OTHER

NCT03183505 - Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb | Biotech Hunter | Biotech Hunter